Pediatric Blood and Marrow Transplant and Cellular Therapy Fellowship
The University of Â鶹´«Ã½¸ßÇå and Children’s Hospital Â鶹´«Ã½¸ßÇå Blood and Marrow Transplantation and Cell Therapy (BMT/CT) group have a one-year clinical pediatric subspecialty training fellowship. The Pediatric BMT/CT fellow will be provided with significant experience in all aspects of malignant and non-malignant pediatric BMT/CT including primary consultation, standard and alternative donor sources, gene therapy, graft manipulation, and manufacture and treatment with CAR-T and CTL products in our GMP facilities. Fellows will lead care for BMT/CT patients in both the inpatient unit, outpatient clinic and infusion center and have a mentored clinical research project with one of our BMT/CT physicians. Fellows will participate in weekly clinical and didactic educational meetings with the malignant, non-malignant, and immunology teams.
The CHCO Program provides FACT accredited BMT/CT care to over 100 patients a year across the western-states region for a variety of conditions including hemoglobinopathies, primary immunodeficiency and dysregulation, marrow failure, leukemia/lymphoma, and solid tumors (CNS and non-CNS). Our program has a large clinical research portfolio and supports investigator-initiated trials.
Admissions and Requirements: Applicants must have successfully completed a pediatric Heme /Onc fellowship and be able to obtain a Â鶹´«Ã½¸ßÇå medical license. Admissions are on a rolling basis, so please contact us at your earliest convenience. CVs are typically reviewed in mid-late summer and interviews offered to selected candidates in October and November.
Application Process: Interested individuals should submit a letter of interest and a CV to the Fellowship Director Dr. Vanessa Fabrizio and email is Vanessa.Fabrizio@CUAnschutz.edu
Diversity and Equity: The University will provide reasonable accommodations to applicants with disabilities throughout the employment application process. To request an accommodation pursuant to the Americans with Disabilities Act, please contact the Human Resources ADA Coordinator at ³ó°ù.²¹»å²¹³¦´Ç´Ç°ù»å¾±²Ô²¹³Ù´Ç°ù°ª³Ü³¦»å±ð²Ô±¹±ð°ù.±ð»å³Ü​.
The University of Â鶹´«Ã½¸ßÇå Denver | Anschutz Medical Campus is committed to recruiting and supporting a diverse student body, faculty and administrative staff. The university strives to promote a culture of inclusiveness, respect, communication and understanding. We encourage applications from women, ethnic minorities, persons with disabilities, persons within the LGBTQ+ community, and all veterans. The University of Â鶹´«Ã½¸ßÇå is committed to diversity and equality in education and employment.
The University of Â鶹´«Ã½¸ßÇå Denver | Anschutz Medical Campus is dedicated to ensuring a safe and secure environment for our faculty, staff, students and visitors. To assist in achieving that goal, we conduct background investigations for all prospective employees.
Clinical care and training is delivered at the Children's Hospital Â鶹´«Ã½¸ßÇå while the larger Anschutz campus provides opportunities within the graduate science programs, school of medicine, school of pharmacy, school of nursing, and other medically intensive professionals.
: Program Lead of the BMT/CT Program, Professor of Pediatrics. Basic science lab investigating NK cell biology and clinical research interests in pediatric malignancy.
: Assistant Professor of Pediatrics. Clinical focus in non-malignant transplant and research interests in transplant for immune dysregulation and survivorship for post-BMT patients.
: Assistant Professor of Pediatrics. Clinical research interests include pediatric BMT and cellular therapies for hematologic malignancies.
: Professor of Pediatrics. Diverse research in all areas of pediatric neuro-oncology with an emphasis on immunobiology of brain tumors and ependymoma. Long standing interest in autologous transplants in pediatric brain tumors.
: Section Chief for the Center for Cancer and Blood Disorders, Professor of Pediatrics. Research interests in developmental therapeutics and emerging therapies for pediatric leukemia.
: Assistant Professor of Pediatrics. Basic science lab investigating CAR-T cell therapy optimization for treatment of hematologic malignancies.
: Assistant Professor of Pediatrics. Translational research laboratory investigating novel cellular therapies for the treatment of solid tumors through modulating the tumor microenvironment.
: Director of Pediatric Hemoglobinopathy Program. Clinical interest in non-malignant transplant for patients with sickle cell, thalassemia and neutrophil disorders such as chronic granulomatous disease. Research interest in autologous gene therapy and improving outcomes using alternative donors for patients with hemoglobinopathies.
: Assistant Professor of Pediatrics. Clinical research interests include development of novel conditioning regimens and improving transplant outcomes, including graft failure, in patients with non-malignant diseases.
: Director of Neuro-Oncology High Dose Therapy/Autologous Transplant Program Children’s Hospital Â鶹´«Ã½¸ßÇå. Research interests include the development of novel therapies for pediatric brain tumors.
: Professor of Pediatrics. Interests in severe combined immunodeficiencies and other genetic immune dysfunctions.